JP3289349B2 - Method for producing D-alanine by fermentation method - Google Patents

Method for producing D-alanine by fermentation method

Info

Publication number
JP3289349B2
JP3289349B2 JP34728992A JP34728992A JP3289349B2 JP 3289349 B2 JP3289349 B2 JP 3289349B2 JP 34728992 A JP34728992 A JP 34728992A JP 34728992 A JP34728992 A JP 34728992A JP 3289349 B2 JP3289349 B2 JP 3289349B2
Authority
JP
Japan
Prior art keywords
alanine
strain
chloro
producing
resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP34728992A
Other languages
Japanese (ja)
Other versions
JPH05308981A (en
Inventor
浩己 筒井
勝成 山田
徹 米原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP34728992A priority Critical patent/JP3289349B2/en
Publication of JPH05308981A publication Critical patent/JPH05308981A/en
Application granted granted Critical
Publication of JP3289349B2 publication Critical patent/JP3289349B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は発酵法によるD−アラニ
ンの製造法に関するものである。
The present invention relates to a method for producing D-alanine by a fermentation method.

【0002】D−アラニンは、非天然型アミノ酸である
が、それ自体試薬としてあるいはペプチドなどの合成原
料として有用な化合物であり近年その需要も増加してい
る。
D-alanine is a non-natural amino acid, but it is a compound useful as a reagent or as a raw material for synthesis of peptides and the like, and its demand has been increasing in recent years.

【0003】[0003]

【従来の技術】従来より、D−シクロセリンに耐性を有
するブレビバクテリウム属に属する微生物により発酵法
によってD−アラニンを製造する方法は知られている
(特開平1−187091号公報)。この方法によれ
ば、選択的にD−アラニンのみを生成蓄積させることが
可能である。
2. Description of the Related Art A method for producing D-alanine by a fermentation method using a microorganism belonging to the genus Brevibacterium having resistance to D-cycloserine has been known (Japanese Patent Application Laid-Open No. 1-187091). According to this method, it is possible to selectively generate and accumulate only D-alanine.

【0004】[0004]

【課題を解決するための手段】しかしながら、得られる
D−アラニンの蓄積量および光学純度が、まだ十分では
なかった。
SUMMARY OF THE INVENTION However, the amount of D-alanine obtained and the optical purity have not been sufficient.

【0005】その結果、本発明者らは、ブレビバクテリ
ウム属に属する微生物であって、特別な耐性を有する微
生物が、改善された蓄積量および光学純度でD−アラニ
ンを選択的に生成蓄積することを見出し、本発明を完成
した。
[0005] As a result, the present inventors have found that microorganisms belonging to the genus Brevibacterium, which have special resistance, selectively produce and accumulate D-alanine with an improved accumulation amount and optical purity. Thus, the present invention has been completed.

【0006】すなわち本発明は、D−アラニン生産能を
有し、かつβ−クロロ−D−アラニンに対して耐性を有
するブレビバクテリウム(Brevibacterium)属に属する微
生物を培養して培養液中にD−アラニンを生成蓄積せし
め、前記培養液よりD−アラニンを採取することを特徴
とする発酵法によるD−アラニンの製造法である。
That is, the present invention provides a method for culturing a microorganism belonging to the genus Brevibacterium having D-alanine producing ability and having resistance to β-chloro-D-alanine. -A method for producing D-alanine by a fermentation method, which comprises producing and accumulating alanine and collecting D-alanine from the culture solution.

【0007】次に本発明を詳細に説明する。Next, the present invention will be described in detail.

【0008】本発明で用いられる微生物はD−アラニン
生産能を有し、かつβ−クロロ−D−アラニンに対して
耐性を有するブレビバクテリウム属に属する微生物であ
る。かかる性質を有していれば、他の要求性、薬剤抵抗
性の性質を持つものでも本発明の範囲に含まれる。
[0008] The microorganism used in the present invention is a microorganism belonging to the genus Brevibacterium which has D-alanine producing ability and is resistant to β-chloro-D-alanine. As long as it has such properties, those having other required and drug-resistant properties are also included in the scope of the present invention.

【0009】本発明で用いられる変異株の代表的なもの
としては、たとえば、ブレビバクテリウム・ラクトファ
ーメンタムHR5−43(微工研菌寄第13338号)
が挙げられる。この変異株は、ブレビバクテリウム・ラ
クトファーメンタムATCC13869より誘導された
D−シクロセリン耐性株ブレビバクテリウム・ラクトフ
ァーメンタムDCSR17−2(FERM BP−20
24)から得られたもので、β−クロロ−D−アラニン
に対して耐性を有する変異株である。
[0009] Representative mutant strains used in the present invention include, for example, Brevibacterium lactofermentum HR5-43 (Microtechnical Laboratory No. 13338).
Is mentioned. This mutant is a D-cycloserine resistant strain Brevibacterium lactofermentum DCSR17-2 (FERM BP-20) derived from Brevibacterium lactofermentum ATCC13869.
24) A mutant strain having resistance to β-chloro-D-alanine.

【0010】変異株の誘導は、通常の変異処理法によっ
て比較的容易にできる。すなわちβ−クロロ−D−アラ
ニンに耐性を有する変異株を得るには親株を紫外線照射
するかあるいは変異誘発剤(たとえば、N−メチル−
N′−ニトロ−N−ニトロソグアニジン、エチルメタン
スルホン酸など)で処理したのち、親株が十分に生育で
きないような量のβ−クロロ−D−アラニンを含む培地
で親株に比べて有意に生育に生育可能な菌株を取得すれ
ばよい。
[0010] Induction of a mutant strain can be relatively easily carried out by a usual mutation treatment method. That is, in order to obtain a mutant strain having resistance to β-chloro-D-alanine, the parent strain is irradiated with ultraviolet light or a mutagen (eg, N-methyl-
N'-nitro-N-nitrosoguanidine, ethyl methanesulfonic acid, etc.), the growth of the parent strain was significantly greater than that of the parent strain in a medium containing an amount of β-chloro-D-alanine such that the parent strain could not grow sufficiently. What is necessary is just to obtain a viable strain.

【0011】本発明におけるβ−クロロ−D−アラニン
耐性株とは、その親株より強い耐性を有する菌株であ
り、好ましくは親株の64時間後の相対生育度が40%
以下になるようなβ−クロロ−D−アラニン濃度を含む
培地で培養した場合の相対生育度が50%以上示すもの
をいう。ここで生育度は、660nmにおける吸光度を測
定し、各菌株のβ−クロロ−D−アラニンを添加してい
ない培養液の吸光度を100%として表わした場合の相
対吸光度で示すものとする。
The β-chloro-D-alanine resistant strain in the present invention is a strain having a higher resistance than its parent strain, and preferably has a relative growth of 40% after 64 hours of the parent strain.
The relative growth rate when cultured in a medium containing a β-chloro-D-alanine concentration as shown below is 50% or more. Here, the growth degree is measured by measuring the absorbance at 660 nm, and is expressed as a relative absorbance when the absorbance of the culture solution of each strain to which β-chloro-D-alanine is not added is expressed as 100%.

【0012】β−クロロ−D−アラニン耐性は実施例に
示すように、D−シクロセリン耐性とは独立した性質で
ありD−アラニン生産性を向上する形質として新規なも
のである。
As shown in Examples, β-chloro-D-alanine resistance is a property independent of D-cycloserine resistance and is a novel trait to improve D-alanine productivity.

【0013】本発明方法で使用する培養液培地として
は、通常微生物の培養に汎用される各種栄養源を使用で
きる。たとえば炭素源としてはグルコース、糖蜜、デン
プン加水分解液などの糖類、酢酸などの有機酸、エタノ
ールなどのアルコール類、安息香酸などの有機化合物、
窒素源としては硫安、硝安、塩安、リン安、尿素、アン
モニア、その他を利用でき、無機アンモニア塩の種類に
よってはたとえばリン酸塩、炭酸カルシウムなどの無機
塩を必要とする場合がある。また上記培地には微生物の
生育をよくし、D−アラニンを著量蓄積させるためにた
とえば、有機窒素源、ビタミン、微量の金属イオンなど
を添加するのが望ましいが通常安価な味液、コーンスチ
ープリカーなどの添加によって十分それらの目的を達成
することができる。
As the culture medium used in the method of the present invention, various nutrients commonly used for culturing microorganisms can be used. For example, as a carbon source, glucose, molasses, sugars such as starch hydrolysate, organic acids such as acetic acid, alcohols such as ethanol, organic compounds such as benzoic acid,
As the nitrogen source, ammonium sulfate, ammonium nitrate, ammonium salt, ammonium phosphate, urea, ammonia, and others can be used. Depending on the type of inorganic ammonium salt, an inorganic salt such as phosphate or calcium carbonate may be required. In order to improve the growth of microorganisms and to accumulate a considerable amount of D-alanine, it is desirable to add, for example, an organic nitrogen source, vitamins, trace amounts of metal ions, etc. to the above-mentioned medium. The purpose can be sufficiently achieved by adding liquor and the like.

【0014】培養は、好気的条件で行う。培養の間、培
地のpHは5から9に、温度は24〜37℃に調節し、
48〜120時間振盪または通気培養すれば好ましい結
果が得られる。
The culture is performed under aerobic conditions. During the cultivation, the pH of the medium was adjusted from 5 to 9, the temperature was adjusted to 24-37 ° C,
Preferred results are obtained by shaking or aeration culture for 48-120 hours.

【0015】培養液よりD−アラニンを採取するには、
通常の方法を用いることができる。たとえば、菌体を除
去した培養濾液をpH2に塩酸で調整したのち、強酸性
カチオンイオン交換樹脂に通液後、希アンモニア水で吸
着成分を溶出し、脱アンモニア後濃縮する。これにアル
コールを添加し、冷却保存下で生成した結晶を集めD−
アラニンを得ることができる。
To collect D-alanine from the culture,
Normal methods can be used. For example, after the culture filtrate from which the cells have been removed is adjusted to pH 2 with hydrochloric acid, the solution is passed through a strongly acidic cation ion exchange resin, the adsorbed components are eluted with dilute aqueous ammonia, deammoniaized, and then concentrated. Alcohol was added thereto, and the crystals formed under cooling and preservation were collected.
Alanine can be obtained.

【0016】[0016]

【実施例】以下、実施例により本発明を具体的に説明す
る。
The present invention will be described below in detail with reference to examples.

【0017】実施例1 (β−クロロ−D−アラニン耐性株の分離) ブレビバクテリウム・ラクトファーメンタムDCSR1
7−2(FERM BP−2024)の菌体に常法によ
りN−メチル−N′−ニトロ−N−ニトロソグアニジン
処理(300μg/ml、30℃で10分)したのち、こ
の細胞をβ−クロロ−D−アラニン0.8g/lを添加
した寒天培地(D−リボース1%、硫安2%、リン酸第
1カリウム0.2%、硫酸マグネシウム・7水和物0.
04%、塩化ナトリウム0.1%、尿素0.5%、硫酸
第1鉄・7水和物20mg/l、硫酸マンガン・4水和物
20mg/l、ビチオン120μg/l、チアミン塩酸塩
60μg/lを含む完全合成培地)に塗布した。次に3
0℃で5〜7日培養し、生じた大きなコロニーを釣菌分
離して、β−クロロ−D−アラニン耐性株(ブレビバク
テリウム・ラクトファーメンタムHR5−43)を取得
した。
Example 1 (Isolation of β-chloro-D-alanine resistant strain) Brevibacterium lactofermentum DCSR1
After the cells of 7-2 (FERM BP-2024) were treated with N-methyl-N'-nitro-N-nitrosoguanidine (300 μg / ml, 10 minutes at 30 ° C.) by a conventional method, the cells were subjected to β-chloroform. -Agar medium supplemented with 0.8 g / l of D-alanine (D-ribose 1%, ammonium sulfate 2%, potassium monophosphate 0.2%, magnesium sulfate heptahydrate 0.1%).
04%, sodium chloride 0.1%, urea 0.5%, ferrous sulfate heptahydrate 20 mg / l, manganese sulfate tetrahydrate 20 mg / l, bition 120 μg / l, thiamine hydrochloride 60 μg / 1 complete synthetic medium). Then 3
The cells were cultured at 0 ° C. for 5 to 7 days, and the resulting large colonies were separated by filtration to obtain β-chloro-D-alanine resistant strains (Brevibacterium lactofermentum HR5-43).

【0018】実施例2 (β−クロロ−D−アラニン耐性株HR5−43の耐性
度) 表1に示す各菌株を液体ブイヨン培地を用いて30℃で
16時間振盪培養し、生育した菌体を集菌し生理食塩水
でよく洗浄した。この菌体懸濁液をβ−クロロ−D−ア
ラニンを各々0、150、300mg/lの濃度で含む最
少培地(培地組成:D−リボース1%、硫安2%、リン
酸第1カリウム0.2%、硫酸マグネシウム・7水和物
0.04%、塩化ナトリウム0.1%、尿素0.5%、
硫酸第1鉄・7水和物20mg/l、硫酸マンガン・4水
和物20mg/l、ビチオン120μg/l、チアミン塩
酸塩60μg/lを含む完全合成培地)5mlに植菌して
30℃で培養した。その結果を表1に示す。
Example 2 (degree of resistance of β-chloro-D-alanine resistant strain HR5-43) Each strain shown in Table 1 was shake-cultured at 30 ° C. for 16 hours using a liquid broth medium, and the cells grown were cultured. The cells were collected and washed well with physiological saline. This cell suspension is a minimal medium containing β-chloro-D-alanine at concentrations of 0, 150, and 300 mg / l, respectively (medium composition: D-ribose 1%, ammonium sulfate 2%, monobasic potassium phosphate 0.1%). 2%, magnesium sulfate heptahydrate 0.04%, sodium chloride 0.1%, urea 0.5%,
Inoculated in 5 ml of a complete synthetic medium containing ferrous sulfate heptahydrate 20 mg / l, manganese sulfate tetrahydrate 20 mg / l, bition 120 μg / l, and thiamine hydrochloride 60 μg / l) at 30 ° C. Cultured. Table 1 shows the results.

【0019】[0019]

【表1】 (注)培養液の660nmにおける吸光度を( )内に記
した。相対生育度は各菌株のβ−クロロ−D−アラニン
を添加していない培養液の吸光度を100%として換算
した。
[Table 1] (Note) The absorbance at 660 nm of the culture solution is shown in parentheses. Relative growth was calculated assuming that the absorbance of the culture solution of each strain to which β-chloro-D-alanine was not added was 100%.

【0020】本発明方法で使用するβ−クロロ−D−ア
ラニン耐性株(HR5−43)ではブレビバクテリウム
・ラクトファーメンタムATCC13869およびD−
シクロセリン耐性株であるブレビバクテリウム・ラクト
ファーメンタムDCSR17−2(FERM BP−2
024)の両菌株と比較して、β−クロロ−D−アラニ
ンによって生育が阻害されず、β−クロロ−D−アラニ
ンに対する耐性を獲得していることが明らかである。
The β-chloro-D-alanine resistant strain (HR5-43) used in the method of the present invention includes Brevibacterium lactofermentum ATCC 13869 and D-
Brevibacterium lactofermentum DCSR17-2 (FERM BP-2) which is a cycloserine resistant strain
024), it is clear that growth was not inhibited by β-chloro-D-alanine and that the strain had acquired resistance to β-chloro-D-alanine.

【0021】実施例3 菌株をそれぞれを液体ブイヨン培地50mlで30℃、
16時間振盪培養した後、あらかじめ120℃、20分
間蒸気滅菌した下記組成の主発酵培地950mlを含む2
リットル容ミニジャファーメンターに植え継ぎ30℃、
500rpm 、通気量0.5vvm にて通気撹拌培養を開始
した。
Example 3 Each strain was placed in a liquid broth medium (50 ml) at 30 ° C.
After shaking culture for 16 hours, containing 950 ml of a main fermentation medium having the following composition, which was previously steam-sterilized at 120 ° C. for 20 minutes.
30 ° C planted in a liter mini jar fermenter
Aeration and agitation culture was started at 500 rpm and an aeration rate of 0.5 vvm.

【0022】主発酵培地 グルコース(別滅菌)5%、(NH4 )2 SO4 0.5
%、KH2 PO4 0.15%、NaCl1.0%、Mg
SO4 ・7H2 O 0.035%、FeSO4 ・7H2
O 0.002%、MnSO4 ・4H2 O 0.002
%、CaSO4 ・2H2 O 0.02%、ビオチン60
μg/l、チアミン・HCl40μg/l
Main fermentation medium Glucose (separately sterilized) 5%, (NH 4) 2 SO 4 0.5
%, KH2 PO4 0.15%, NaCl 1.0%, Mg
0.035% SO4.7H2O, FeSO4.7H2
O 0.002%, MnSO4.4H2 O 0.002
%, CaSO4.2H2 O 0.02%, biotin 60
μg / l, Thiamine / HCl 40 μg / l

【0023】pH調節および窒素源の供給は25%のア
ンモニア水にて行い、pHは6.0〜8.0に維持し
た。グルコースを適宜添加しながら、72時間培養した
ところ、蓄積濃度、D−アラニン生成収率ともいずれの
場合も、親株であるD−シクロセリン耐性株であるブレ
ビバクテリウム・ラクトファーメンタムDCSR17−
2(FERM BP−2024)に比べて有意に向上し
た。
The pH was adjusted and the nitrogen source was supplied with 25% aqueous ammonia, and the pH was maintained at 6.0 to 8.0. While adding glucose as appropriate, were cultured for 72 hours, accumulation density in any case also D- alanine production yield is the parent strain D- cycloserine resistant a strain Brevibacterium lactofermentum DCSR17-
2 (FERM BP-2024).

【0026】ブレビバクテリウム・ラクトファーメンタ
ムHR5−43の発酵液より菌体を除き、その500ml
を強カチオン交換樹脂ダイヤイオンSK1−B(H型)
のカラムに通した。カラムを水洗後、2Nアンモニア水
でカラムの吸着成分を溶出し、脱色後減圧濃縮した。こ
れにエタノールを加え、冷却し生成した結晶を集めて乾
燥した結果、D−アラニンの結晶19.1gを得た。な
お、得られたD−アラニン結晶の光学純度は99%以上
であった。
The cells were removed from the fermented broth of Brevibacterium lactofermentum HR5-43 and its 500 ml
Is a strong cation exchange resin Diaion SK1-B (H type)
Through the column. After washing the column with water, the adsorbed components of the column were eluted with 2N aqueous ammonia, and after decolorization, concentrated under reduced pressure. Ethanol was added thereto, the mixture was cooled, and the generated crystals were collected and dried. As a result, 19.1 g of D-alanine crystals were obtained. The optical purity of the obtained D-alanine crystal was 99% or more.

【0027】[0027]

【発明の効果】本発明によれば発酵法により高蓄積濃度
かつ高光学純度でD−アラニンを生成蓄積させることが
可能になった。そのためより安価にD−アラニンを取得
することができるようになり、その工業価値は大きい。
According to the present invention, it has become possible to produce and accumulate D-alanine with high accumulation concentration and high optical purity by fermentation. Therefore, D-alanine can be obtained at lower cost, and its industrial value is great.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) C12P 13/06 BIOSIS(DIALOG) WPI(DIALOG)──────────────────────────────────────────────────続 き Continued on the front page (58) Fields surveyed (Int. Cl. 7 , DB name) C12P 13/06 BIOSIS (DIALOG) WPI (DIALOG)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 D−アラニン生産能を有し、かつβ−ク
ロロ−D−アラニンに対して耐性を有するブレビバクテ
リウム(Brevibacterium)属に属する微生物を培養して、
培養液中にD−アラニンを生成蓄積せしめ、前記培養液
よりD−アラニンを採取することを特徴とする発酵法に
よるD−アラニンの製造法。
1. A microorganism belonging to the genus Brevibacterium having D-alanine producing ability and having resistance to β-chloro-D-alanine is cultured,
A method for producing D-alanine by a fermentation method, wherein D-alanine is produced and accumulated in a culture solution, and D-alanine is collected from the culture solution.
JP34728992A 1991-12-27 1992-12-25 Method for producing D-alanine by fermentation method Expired - Fee Related JP3289349B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP34728992A JP3289349B2 (en) 1991-12-27 1992-12-25 Method for producing D-alanine by fermentation method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34753291 1991-12-27
JP3-347532 1991-12-27
JP34728992A JP3289349B2 (en) 1991-12-27 1992-12-25 Method for producing D-alanine by fermentation method

Publications (2)

Publication Number Publication Date
JPH05308981A JPH05308981A (en) 1993-11-22
JP3289349B2 true JP3289349B2 (en) 2002-06-04

Family

ID=26578473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34728992A Expired - Fee Related JP3289349B2 (en) 1991-12-27 1992-12-25 Method for producing D-alanine by fermentation method

Country Status (1)

Country Link
JP (1) JP3289349B2 (en)

Also Published As

Publication number Publication date
JPH05308981A (en) 1993-11-22

Similar Documents

Publication Publication Date Title
JP3006926B2 (en) Method for producing L-threonine by fermentation method
JP3151073B2 (en) Production of amino acids by fermentation
JPH05130882A (en) Production of l-isoleucine by fermentation
JPS5816872B2 (en) Corynebacterium glutamicum mutant strain
JPH04262790A (en) Production of 5'-xanthylic acid by fermentation
JP3131311B2 (en) Production method of L-isoleucine by fermentation method
JPH0632626B2 (en) Fermentation method for producing L-threonine
US3734829A (en) Fermentative preparation of l-arginine
JP3289349B2 (en) Method for producing D-alanine by fermentation method
US3902967A (en) Process for producing L-arginine by fermentation
JPS5922516B2 (en) Method for producing L-phenylalanine
US3880741A (en) Method of producing L-serine
JP3100763B2 (en) Method for producing L-arginine by fermentation
JP2833084B2 (en) Production method of L-proline by fermentation method
JPH03236786A (en) Production of l-threonine by fermentation method
EP0310949B1 (en) Process for producing d-alanine
US3531372A (en) Process of producing diaminopimelic acid
JPH1042883A (en) Production of inositol and collection of strain resistant to 6-halogeno-6-deoxyglucose
JPH1042860A (en) Production of inositol and acquirement of hexachlorocyclohexane-resistant strain
JPS63254990A (en) Production of l-threonine by fermentation method
JPH04248988A (en) Production of l-proline by fermentation method
JPH0673461B2 (en) Fermentation method for producing L-threonine
JPS63160592A (en) Production of l-valine
JPS6244192A (en) Production of l-threonine by fermentation
JPH0563156B2 (en)

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees